GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 57 filers reported holding GT BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 2.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,513 | -23.3% | 10,424 | -0.7% | 0.00% | – |
| Q2 2023 | $3,276 | -43.3% | 10,500 | -0.1% | 0.00% | – |
| Q1 2023 | $5,779 | -38.1% | 10,507 | -0.4% | 0.00% | – |
| Q4 2022 | $9,340 | -78.8% | 10,545 | -57.9% | 0.00% | – |
| Q3 2022 | $44,000 | +37.5% | 25,034 | +135.0% | 0.00% | – |
| Q2 2022 | $32,000 | +3.2% | 10,652 | -0.2% | 0.00% | – |
| Q1 2022 | $31,000 | -85.7% | 10,677 | -85.0% | 0.00% | – |
| Q4 2021 | $217,000 | -38.5% | 71,234 | +35.9% | 0.00% | – |
| Q3 2021 | $353,000 | – | 52,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silverleafe Capital Partners, LLC | 105,000 | $708,000 | 0.28% |
| Welch Group, LLC | 10,000 | $67,000 | 0.01% |
| Cubist Systematic Strategies, LLC | 33,703 | $227,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 14,260 | $96,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 15,000 | $101,000 | 0.00% |
| ExodusPoint Capital Management, LP | 22,200 | $150,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 162,823 | $1,097,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 51,100 | $344,000 | 0.00% |
| TimeScale Financial, Inc. | 549 | $4,000 | 0.00% |
| Hartford Financial Management Inc. | 500 | $3,000 | 0.00% |